Spring Point Project

Organization Overview

Spring Point Project is located in Minneapolis, MN. The organization was established in 2005. According to its NTEE Classification (H80) the organization is classified as: Specifically Named Diseases Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Spring Point Project employed 15 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Spring Point Project is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2023, Spring Point Project generated $3.7m in total revenue. The organization has seen a slow decline revenue. Over the past 9 years, revenues have fallen by an average of (1.4%) each year. All expenses for the organization totaled $3.2m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2023

Describe the Organization's Mission:

Part 3 - Line 1

PROVIDE MEDICAL-GRADE PORCINE ISLETS TO REPLACE THOSE LOST IN TYPE 1 DIABETES.

Describe the Organization's Program Activity:

Part 3 - Line 4a

BRED AND RAISED DESIGNATED PATHOGEN-FREE (DPF) MEDICAL-GRADE PIGS FOR USE IN BIOMEDICAL RESEARCH TO TREAT AND POTENTIALLY CURE TYPE 1 DIABETES. PANCREAS PROCUREMENT, ISLET ISOLATION AND ENCAPSULATION ACTIVITIES ARE UNDERWAY TO ENABLE INVESTIGATIONAL NEW DRUG APPLICATION (IND) PREPARATION, WHICH IS NECESSARY FOR CLINICAL STUDIES. THE LONG-TERM PROGRAM OBJECTIVE IS TO PRODUCE A SUFFICIENT SUPPLY OF SUITABLE DONOR PIGS TO SERVE AS ISLET DONORS FOR DIABETIC PATIENTS, ULTIMATELY LEADING TO A CURE FOR DIABETES.TO DATE, PRODUCED OVER THREE THOUSAND DPF PIGS AND MANUFACTURED AND ISOLATED OVER 173 MILLION PORCINE ISLETS FROM DESIGNATED PATHOGEN-FREE (DPF) ANIMALS PRODUCED AT THE ORGANIZATION'S FACILITY TO SUPPORT (1) PRECLINICAL TRANSPLANTATION STUDIES AND PHASE I/II CLINICAL PREPARATION ACTIVITIES AND (2) THE VALIDATION OF THE CGMP MANUFACTURING OF A CLINICALLY SUITABLE PRODUCT IN THE ON-SITE CELLULAR MANUFACTURING FACILITY. PROCURED PORCINE PANCREASES FROM DPF PIGLETS AND PROVIDED TO RESEARCHERS FOR STUDIES TO DEVELOP A NOVEL PRODUCT FOR THE TREATMENT OF TYPE 1 DIABETES AND OTHER DISEASES.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Patrick Ryan
Chairman
$0
Timothy Clark
Executive Vice Chairman
$0
Steve Murphy
Treasurer
$0
Martha Vetter
Secretary
$0
Chris Prue
Director
$0
Christian Gretschel
Director
$0

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Envigo Rms Llc
Animal Feed Provider
$195,954
Avantor
Product Manufacturing Supplies And Porci
$184,504
Eurofins Lancaster Laboratories Inc
Product Mycoplasma Testing
$128,302
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$6,815
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$6,815
Total Program Service Revenue$3,360,225
Investment income $74,243
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $402
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $3,706,775

Create an account to unlock the data you need.

or